BFGF promotes the differentiation and effectiveness of human bone marrow mesenchymal stem cells in a rotenone model for Parkinson's disease

Environmental Toxicology and Pharmacology

Volumn 36, Issue 2, 2013, Pages 411-422

  Xiong, Nian ^a   Yang, Hecheng ^a   Liu, Ling ^a   Xiong, Jing ^a   Zhang, Zhaowen ^a   Zhang, Xiaowei ^a   Jia, Min ^a   Huang, Jinsha ^a   Zhang, Zhentao ^a,b   Mohamed, Asrah A ^a   Lin, Zhicheng ^c,d,e   Wang, Tao ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MCLEAN HOSPITAL   (United States)

^e The Harvard Center for Neurodegeneration & Repair   (United States)

Author keywords

Basic fibroblast growth factor; Dopaminergic neurons; Human bone marrow mesenchymal stem cells; Multipotency; Parkinson's disease; Rotenone

Indexed keywords

RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; ROTENONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW MESENCHYMAL STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL LINEAGE; CELL LOSS; CELL VIABILITY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE MODEL; DOPAMINERGIC NERVE CELL; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR PERFORMANCE; MULTIPOTENT STEM CELL; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

BASIC FIBROBLAST GROWTH FACTOR; BFGF; BMSCS; BONE MARROW MESENCHYMAL STEM CELLS; CORPUS STRIATUM; CPU; DAT; DOPAMINE TRANSPORTER; DOPAMINERGIC NEURONS; GFAP; GLIAL FIBRILLARY ACIDIC PROTEIN; HBMSCS; HUMAN BMSCS; HUMAN BONE MARROW MESENCHYMAL STEM CELLS; MULTIPOTENCY; NEURON-SPECIFIC ENOLASE; NSE; PARKINSON'S DISEASE; PD; ROTENONE; SNC; SUBSTANTIA NIGRA PARS COMPACTA; TEM; TH; TJMC & HUST; TONGJI MEDICAL COLLEGE, HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY; TRANSMISSION ELECTRON MICROSCOPE; TYROSINE HYDROXYLASE; VENTRAL TEGMENTAL AREA; VTA;

ANIMALS; BEHAVIOR, ANIMAL; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MOTOR ACTIVITY; NEUROGENESIS; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; ROTENONE; TIME FACTORS;

ANIMALIA; PARKINSONIA; RATTUS;

EID: 84879344952     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2013.05.005     Document Type: Article

References (33)

1. Akino K., Mineta T., Fukui M., Fujii T., Akita S. Bone morphogenetic protein-2 regulates proliferation of human mesenchymal stem cells. Wound Repair Regen. 2003, 11:354-360. Official publication of the Wound Healing Society [and] the European Tissue Repair Society.
2. Barzilay R., Ben-Zur T., Bulvik S., Melamed E., Offen D. Lentiviral delivery of LMX1a enhances dopaminergic phenotype in differentiated human bone marrow mesenchymal stem cells. Stem Cells Dev. 2009, 18:591-601.
3. Barzilay R., Kan I., Ben-Zur T., Bulvik S., Melamed E., Offen D. Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols. Stem Cells Dev. 2008, 17:547-554.
4. Bhang S.H., Lee Y.E., Cho S.W., Shim J.W., Lee S.H., Choi C.Y., Chang J.W., Kim B.S. Basic fibroblast growth factor promotes bone marrow stromal cell transplantation-mediated neural regeneration in traumatic brain injury. Biochem. Biophys. Res. Commun. 2007, 359:40-45.
5. Deierborg T., Soulet D., Roybon L., Hall V., Brundin P. Emerging restorative treatments for Parkinson's disease. Prog. Neurobiol. 2008, 85:407-432.
6. Delcroix G.J., Garbayo E., Sindji L., Thomas O., Vanpouille-Box C., Schiller P.C., Montero-Menei C.N. The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats. Biomaterials 2011, 32:1560-1573.
7. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., Eidelberg D., Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 2001, 344:710-719.
8. Hori Y., Inoue S., Hirano Y., Tabata Y. Effect of culture substrates and fibroblast growth factor addition on the proliferation and differentiation of rat bone marrow stromal cells. Tissue Eng. 2004, 10:995-1005.
9. Jiang J., Lv Z., Gu Y., Li J., Xu L., Xu W., Lu J., Xu J. Adult rat mesenchymal stem cells differentiate into neuronal-like phenotype and express a variety of neuro-regulatory molecules in vitro. Neurosci. Res. 2010, 66:46-52.
10. Jiang X., Zou S., Ye B., Zhu S., Liu Y., Hu J. bFGF-modified BMMSCs enhance bone regeneration following distraction osteogenesis in rabbits. Bone 2010, 46:1156-1161.
11. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada D.A., Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
12. Jin G.Z., Cho S.J., Choi E.G., Lee Y.S., Yu X.F., Choi K.S., Yee S.T., Jeon J.T., Kim M.O., Kong I.K. Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro. Cell Biol. Int. 2008, 32:1433-1438.
13. Karp J.M., Leng Teo G.S. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 2009, 4:206-216.
14. Laskowski A., Schmidt W., Dinkel K., Martinez-Sanchez M., Reymann K.G. bFGF and EGF modulate trauma-induced proliferation and neurogenesis in juvenile organotypic hippocampal slice cultures. Brain Res. 2005, 1037:78-89.
15. Lee S.T., Chu K., Jung K.H., Kim S.J., Kim D.H., Kang K.M., Hong N.H., Kim J.H., Ban J.J., Park H.K., Kim S.U., Park C.G., Lee S.K., Kim M., Roh J.K. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 2008, 131:616-629.
16. Li Y., Chen J., Wang L., Zhang L., Lu M., Chopp M. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neurosci. Lett. 2001, 316:67-70.
17. Lindvall O., Hagell P. Role of cell therapy in Parkinson disease. Neurosurg. Focus 2002, 13:e2.
18. Mezey E., Key S., Vogelsang G., Szalayova I., Lange G.D., Crain B. Transplanted bone marrow generates new neurons in human brains. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:1364-1369.
19. Neubauer M., Fischbach C., Bauer-Kreisel P., Lieb E., Hacker M., Tessmar J., Schulz M.B., Goepferich A., Blunk T. Basic fibroblast growth factor enhances PPARgamma ligand-induced adipogenesis of mesenchymal stem cells. FEBS Lett. 2004, 577:277-283.
20. Ramirez J.J., Finklestein S.P., Keller J., Abrams W., George M.N., Parakh T. Basic fibroblast growth factor enhances axonal sprouting after cortical injury in rats. Neuroreport 1999, 10:1201-1204.
21. Sadan O., Bahat-Stromza M., Barhum Y., Levy Y.S., Pisnevsky A., Peretz H., Ilan A.B., Bulvik S., Shemesh N., Krepel D., Cohen Y., Melamed E., Offen D. Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease. Stem Cells Dev. 2009, 18:1179-1190.
22. Tatard V.M., Venier-Julienne M.C., Benoit J.P., Menei P., Montero-Menei C.N. In vivo evaluation of pharmacologically active microcarriers releasing nerve growth factor and conveying PC12 cells. Cell Transplant. 2004, 13:573-583.
23. Trzaska K.A., Kuzhikandathil E.V., Rameshwar P. Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells 2007, 25:2797-2808.
24. Wakabayashi K., Nagai A., Sheikh A.M., Shiota Y., Narantuya D., Watanabe T., Masuda J., Kobayashi S., Kim S.U., Yamaguchi S. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J. Neurosci. Res. 2010, 88:1017-1025.
25. Wang K., Wang J.J., Wang Y., He Q.H., Wang X., Wang X.M. Infusion of epidermal growth factor and basic fibroblast growth factor into the striatum of parkinsonian rats leads to in vitro proliferation and differentiation of adult neural progenitor cells. Neurosci. Lett. 2004, 364:154-158.
26. Xiong N., Cao X., Zhang Z., Huang J., Chen C., Jia M., Xiong J., Liang Z., Sun S., Lin Z., Wang T. Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats. Biol. Blood Marrow Transplant. 2010, 16:1519-1529.
27. Xiong N., Huang J., Zhang Z., Xiong J., Liu X., Jia M., Wang F., Chen C., Cao X., Liang Z., Sun S., Lin Z., Wang T. Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease. PLoS ONE 2009, 4:e7878.
28. Xiong N., Zhang Z., Huang J., Chen C., Jia M., Xiong J., Liu X., Wang F., Cao X., Liang Z., Sun S., Lin Z., Wang T. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease. Gene Ther. 2011, 18:394-402.
29. Xue X.J., Yuan X.B. Nestin is essential for mitogen-stimulated proliferation of neural progenitor cells. Mol. Cell. Neurosci. 2010, 45:26-36.
30. Ye M., Wang X.J., Zhang Y.H., Lu G.Q., Liang L., Xu J.Y., Sheng-Di C. Therapeutic effects of differentiated bone marrow stromal cell transplantation on rat models of Parkinson's disease. Parkinsonism Relat. Disord. 2007, 13:44-49.
31. Yedjou C.G., Rogers C., Brown E., Tchounwou P.B. Differential effect of ascorbic acid and n-acetyl-l-cysteine on arsenic trioxide-mediated oxidative stress in human leukemia (HL-60) cells. J. Biochem. Mol. Toxicol. 2008, 22:85-92.
32. Yoshimura S., Teramoto T., Whalen M.J., Irizarry M.C., Takagi Y., Qiu J., Harada J., Waeber C., Breakefield X.O., Moskowitz M.A. FGF-2 regulates neurogenesis and degeneration in the dentate gyrus after traumatic brain injury in mice. J. Clin. Invest. 2003, 112:1202-1210.
33. Zanini C., Bruno S., Mandili G., Baci D., Cerutti F., Cenacchi G., Izzi L., Camussi G., Forni M. Differentiation of mesenchymal stem cells derived from pancreatic islets and bone marrow into islet-like cell phenotype. PLoS ONE 2011, 6:e28175.